Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
about
The P2X7 receptor is a key modulator of aerobic glycolysisPurinergic signalling and cancerAggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based ImmunotherapyThe Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and ProgressionThe multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic diseaseChanges of HMGB1 and sRAGE during the recovery of COPD exacerbationThe association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancerHMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.HMGB1 in health and disease.Hypoxia promotes epithelial--mesenchymal transition of hepatocellular carcinoma cells via inducing GLIPR-2 expression.Distinct phenotypes of human prostate cancer cells associate with different adaptation to hypoxia and pro-inflammatory gene expression.P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling.HMGB1 in cancer: good, bad, or both?HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells.Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?Regulation and dysregulation of astrocyte activation and implications in tumor formation.Investigation of phosphoproteome in RAGE signaling.Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.Extracellular purines, purinergic receptors and tumor growth.Transcriptional regulation of Mcl-1 plays an important role of cellular protective effector of vincristine-triggered autophagy in oral cancer cells.RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.Stabilization of Snail by HIF-1α and TNF-α is required for hypoxia-induced invasion in prostate cancer PC3 cells.Knockdown of RAGE inhibits growth and invasion of gastric cancer cells.RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.Hypoxia driven glycation: Mechanisms and therapeutic opportunities.Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1.Purinoreceptor P2X7 Regulation of Ca(2+) Mobilization and Cytoskeletal Rearrangement Is Required for Corneal Reepithelialization after Injury.Targeted P2X7 R shRNA delivery attenuates sympathetic nerve sprouting and ameliorates cardiac dysfunction in rats with myocardial infarction.Macrophages, Inflammation, and Lung Cancer.Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers.IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion.
P2860
Q24296731-140A411F-6602-4BA7-8068-7C9B58364C41Q24618782-D30FC899-8A55-41C5-9F16-D58874072CACQ26738966-C4336EB4-9CFF-44AC-8B9E-7143154777BBQ26765594-BC6777FA-FA62-497A-88E3-C2409A0FF2E9Q26769965-CBAADEE5-4242-4FD6-BE20-1C9C2534FEC6Q28830568-EB7206DE-62FF-4C05-9ED2-A2B97FBBC219Q33814669-7411232B-889A-4A1F-82C3-46E4D8A03581Q34428389-B85068AA-1A2C-45EC-90EC-14135A84CC66Q34541682-EDA1CFD8-81E6-4683-8233-72B49716A5D2Q34588764-65E3BB54-79CF-4D40-A3F2-35F425197929Q34622835-4F35683F-E076-470A-BC55-1E8DD1EE37E6Q35035315-0325C5EE-CAF0-45FC-B144-A4B5DFE98B00Q35163931-75AA8C8D-3257-4E0F-B170-1D7E09A14FDCQ36092896-9F5F2953-A27C-4315-972A-53F2307D242EQ36231977-C44E1B93-BC47-41C3-9014-73836DC2614CQ36310954-0ABC76CC-F838-4FCC-9F7E-874695158EEAQ36691226-1B4E8071-E9D5-43DD-9302-B65A0FAFEA0DQ37067481-76F85B37-BECB-414F-AD27-5593833A79F4Q37504324-039D6DF1-09AB-4907-A894-ED35B5C79BAAQ38081415-72E24BD2-7FDB-48A7-8337-8D3938E16203Q38082722-6FD76BC5-A151-41AB-B5A7-407BABD858B9Q38260264-9EA3311E-C2B9-40F7-BC15-AB1728B1C0B7Q38743691-B1158BD7-218C-4E38-9E47-6DD82D9D6C9AQ38830526-94E82D98-B6B9-495D-94E0-14FA8DEA0FF4Q38870205-A8C6A4C9-DEAA-457D-A810-CA091B8DBBB0Q38917462-4B9AAA8D-4634-43E6-BBFF-D6AFC9AB0D50Q38982380-95015189-1B28-465A-A653-ED28EE228C87Q39017218-D4886BE2-9644-45A5-BD70-2B0A07F798ABQ39033012-D9E23AF8-E8C4-4FFE-B42C-EB9845C22AE1Q39068126-FEF9822D-A5A1-4EEF-8253-584649927E7FQ39093077-630AAA2E-CC08-49F6-8959-01C9EB15258FQ39161005-910CD06A-16BA-4C28-8002-9EC751F59EB8Q39331191-82472318-A6A6-46C4-A4F3-18EA03E54BBDQ39396939-8CA78B06-890F-4BC0-8228-2E03213F90CCQ39438867-5284035B-B0DC-48CD-98A1-9A59D1A347F2Q40194516-7D87D1C2-567C-4228-A561-514D936C0F0FQ40400833-49BEFA2C-BDBF-4BDB-9D0A-1767F8F35870Q41113415-77DCD7B7-442E-499C-B379-13E439E5E891Q41532713-429776B2-197D-42DA-BE6C-8994A0BE17A3Q42844924-5CDD19BB-E295-4131-8BE8-DE3718BB7155
P2860
Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Hypoxia-increased RAGE and P2X ...... translocation of NF-{kappa}B.
@en
Hypoxia-increased RAGE and P2X ...... translocation of NF-{kappa}B.
@nl
type
label
Hypoxia-increased RAGE and P2X ...... translocation of NF-{kappa}B.
@en
Hypoxia-increased RAGE and P2X ...... translocation of NF-{kappa}B.
@nl
prefLabel
Hypoxia-increased RAGE and P2X ...... translocation of NF-{kappa}B.
@en
Hypoxia-increased RAGE and P2X ...... translocation of NF-{kappa}B.
@nl
P2093
P2860
P356
P1433
P1476
Hypoxia-increased RAGE and P2X ...... translocation of NF-{kappa}B.
@en
P2093
Bruna Pucci
Gabriella Marfe
Laura Pellegrini
Lidia Villanova
Luana Schito
Manuela Indelicato
Marco Tafani
Massimo Fini
Matteo A Russo
Roberta Rosa
P2860
P304
P356
10.1093/CARCIN/BGR101
P407
P577
2011-06-03T00:00:00Z